$5.23
1.75% day before yesterday
Nasdaq, Oct 03, 10:12 pm CET
ISIN
NL0015000DX5
Symbol
ATAI

ATAI Life Sciences N.V. Stock price

$5.23
+0.71 15.71% 1M
+3.92 297.72% 6M
+3.90 293.23% YTD
+4.17 393.40% 1Y
+1.91 57.53% 3Y
-14.22 73.11% 5Y
-14.22 73.11% 10Y
-14.22 73.11% 20Y
Nasdaq, Closing price Fri, Oct 03 2025
+0.09 1.75%
ISIN
NL0015000DX5
Symbol
ATAI
Industry

Key metrics

Basic
Market capitalization
$1.1b
Enterprise Value
$1.0b
Net debt
positive
Cash
$95.9m
Shares outstanding
212.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
485.3 | 447.7
EV/Sales
446.4 | 411.8
EV/FCF
negative
P/B
7.8
Financial Health
Equity Ratio
73.0%
Return on Equity
-128.4%
ROCE
-41.0%
ROIC
-76.1%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$2.3m | $2.5m
EBITDA
$-66.4m | $-99.8m
EBIT
$-67.1m | $-100.4m
Net Income
$-80.5m | $-105.7m
Free Cash Flow
$-81.8m
Growth (TTM | estimate)
Revenue
507.9% | 707.7%
EBITDA
38.4% | -0.5%
EBIT
37.9% | -0.7%
Net Income
-38.5% | 29.2%
Free Cash Flow
-3.3%
Margin (TTM | estimate)
Gross
-
EBITDA
-2,869.2% | -3,985.9%
EBIT
-2,901.7%
Net
-3,476.5% | -4,220.2%
Free Cash Flow
-3,535.3%
More
EPS
$-0.4
FCF per Share
$-0.4
Short interest
10.0%
Employees
54
Rev per Employee
$10.0k
Show more

Is ATAI Life Sciences N.V. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

ATAI Life Sciences N.V. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a ATAI Life Sciences N.V. forecast:

14x Buy
93%
1x Hold
7%

Analyst Opinions

15 Analysts have issued a ATAI Life Sciences N.V. forecast:

Buy
93%
Hold
7%

Financial data from ATAI Life Sciences N.V.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2.31 2.31
508% 508%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 35 35
38% 38%
1,526%
- Research and Development Expense 34 34
33% 33%
1,481%
-66 -66
38% 38%
-2,874%
- Depreciation and Amortization 0.75 0.75
121% 121%
32%
EBIT (Operating Income) EBIT -67 -67
38% 38%
-2,907%
Net Profit -80 -80
39% 39%
-3,483%

In millions USD.

Don't miss a Thing! We will send you all news about ATAI Life Sciences N.V. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ATAI Life Sciences N.V. Stock News

Positive
Proactive Investors
2 days ago
atai Life Sciences (NASDAQ:ATAI, ETR:9VC) chief scientific officer Glenn Short spoke with Proactive about the company's recent NIH grant and its innovative discovery program targeting opioid use disorder (OUD).  Short explained that the NIH grant review process is “highly competitive,” with independent experts assessing the novelty and potential impact of atai's work.
Positive
Seeking Alpha
4 days ago
Atai Life Sciences N.V. has surged >275% YTD, driven by promising psychedelic drug candidates targeting treatment-resistant depression and other mental health disorders. ATAI's lead asset, BPL-003, shows strong, durable efficacy in early trials, potentially surpassing Spravato, but regulatory and scheduling hurdles remain significant risks. Despite a tight cash position and upcoming milestones,...
Positive
The Motley Fool
12 days ago
Atai Life Sciences (ATAI 14.96%), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15% that day, thanks to quite positive results from a clinical trial of an investigational drug.
More ATAI Life Sciences N.V. News

Company Profile

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.

Head office Netherlands
CEO Dr. Rao
Employees 54
Founded 2018
Website atai.life

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today